Evidence map›Paper›PMID 34834112›Full record

ArticleMolecules (Basel, Switzerland)2021

Anti-Tumor Effects of Queen Bee Acid (10-Hydroxy-2-Decenoic Acid) Alone and in Combination with Cyclophosphamide and Its Cellular Mechanisms against Ehrlich Solid Tumor in Mice.

Aishah E Albalawi, Norah A Althobaiti, Salma Saleh Alrdahe, Reem Hasaballah Alhasani, Fatima S Alaryani, Mona Nasser BinMowyna

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Royal Jelly: Biological Action and Health Benefits.International journal of molecular sciences · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. 10-Hydroxy-Animals : an open access journal from MDPI · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Aishah E AlbalawiDepartment of Biology, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0002-7695-8691
Norah A AlthobaitiDepartment of Biology, College of Science and Humanities-Al Quwaiiyah, Shaqra University, Al Quwaiiyah 19257, Saudi Arabia.ORCID 0000-0001-6893-5521
Salma Saleh AlrdaheDepartment of Biology, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.
Reem Hasaballah AlhasaniDepartment of Biology, Faculty of Applied Science, Umm Al-Qura University, Makkah 21961, Saudi Arabia.ORCID 0000-0002-6882-7827
Fatima S AlaryaniDepartment of Biology, Faculty of Sciences, University of Jeddah, Jeddah 21959, Saudi Arabia.
Mona Nasser BinMowynaCollege of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia.
Shaqra University · SAUniversity of Tabuk · SAUmm al-Qura University · SAUniversity of Jeddah · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Queen bee acid or 10-hydroxy-2-decenoic acid (10-HDA) is one of the main and unique lipid components (fatty acids) in royal jelly. Previous studies have demonstrated that 10-HDA has various pharmacological and biological activities. The present study aims to evaluate the anti-tumor effects of 10-HDA alone and combined with cyclophosphamide (CP), as an alkylating agent which widely used for the treatment of neoplastic cancers, against the Ehrlich solid tumors (EST) in mice. Methods: A total of 72 female Swiss albino mice were divided into eight groups. EST mice were treated with 10-HDA (2.5 and 5 mg/kg) alone and combined with CP (25 mg/kg) orally once a day for 2 weeks. Tumor growth inhibition, body weight, the serum level of alpha-fetoprotein (AFP) and carcinoembryonic antigen tumor (CAE), liver and kidney enzymes, tumor lipid peroxidation (LPO) and nitric oxide (NO), antioxidant enzymes (e.g. glutathione reductase (GR), glutathione peroxidase (GPx), catalase enzyme (CAT)), tumor necrosis factor alpha level (TNF-α), and the apoptosis-regulatory genes expression were assessed in tested mice. Results: the findings exhibited that treatment of EST-suffering mice with 10-HDA at the doses of 2.5 and 5 mg/kg especially in combination with CP significantly (

Indexed as

Carcinoma, Ehrlich TumorAnimalsAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDose-Response Relationship, DrugFatty AcidsFatty Acids, MonounsaturatedFemaleMiceNeoplasm ProteinsRoyal Jelly10-hydroxy-2-decenoic acidCyclophosphamideFatty AcidsFatty Acids, MonounsaturatedNeoplasm ProteinsRoyal Jellybreast cancercancerin vivonatural productsroyal jellytreatment

Identifiers

PMID34834112
PMCPMC8617861
OpenAlexW3216884219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.